Supplier log in
Musculoskeletal Secondary Care Clinical Advisory Group
Details
| RFx ID : | 31344885 |
| Tender Name : | Musculoskeletal Secondary Care Clinical Advisory Group |
| Reference # : | |
| Open Date : | Wednesday, 26 March 2025 9:30 AM (Pacific/Auckland UTC+13:00) |
| Close Date : | Wednesday, 16 April 2025 5:00 PM (Pacific/Auckland UTC+12:00) |
| Tender Type : | Registration of Interest (ROI) |
| Tender Coverage : | Sole Agency [?] |
| Categories : |
|
| Regions: |
|
| Required Pre-qualifications : | None |
| Contact : |
Sara Brown 04-816-6911 |
| Alternate Physical Delivery Address : | |
| Alternate Physical Fax Number : |
The secondary care sector plays a crucial role in helping people recover from injuries and return to their daily lives.
We value the sector’s role and believe the sector has a wealth of ideas on how we can work more efficiently and effectively together to positively impact your patients’ recovery journey.
We are wanting to form a Musculoskeletal Secondary Care Clinical Advisory Group to provide guidance to the Accident Compensation Corporation (ACC) on potential solutions that will have a positive impact on recovery outcomes. Our initial focus will be on people who have a musculoskeletal injury.
We’re looking for a group of senior clinical secondary care representatives who want to partner with us to help address the shared challenge and improve recovery outcomes for all New Zealanders.
Responsibilities of the Musculoskeletal Secondary Care Clinical Advisory Group (MSK SCCAG)
The MSK SCCAG will:
• meet on a regular basis with ACC.
• provide advice to understand and explain ACC performance insights within the secondary care setting.
• provide advice on priority areas that will improve the rehabilitation outcomes for clients with musculoskeletal injuries.
• identify opportunities for new or enhanced investment in services that support improved rehabilitation outcomes.
• identify opportunities for disinvestment in services that are not supporting rehabilitation outcomes.
• provide advice on how to develop evidence based clinical pathways building on national and international experience and evidence.
